TEC News

TEC News

Strategic Alliances for Medications Development to Treat Substance Use Disorders (R01-Clinical Trial Optional)

Grant Opportunities

The purpose of this Funding Opportunity Announcement (FOA) is to support research that advances compounds towards FDA approval by leveraging NIDA funds with the strengths and resources of outside organizations, such as for-profit and not-for-profit entities, including academic institutions, pharmaceutical and biotechnology companies, private and public foundations, and small businesses. Applications from single entities that possess considerable resources for medications development will also be considered, provided the entity demonstrates a significant resource commitment to the proposed project.

Closing Date: Sep. 1, 2022

View Grant Opportunity